Scientia Research Institute Sp. z o.o
Scientia Research Institute Sp. z o.o is recorded as a service provider in 11 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 11 of 11 trials · Latest update first
Use of Empagliflozin in Patients with Hypertrophic Cardiomyopathy
Sponsor Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of metformin effect on the fertility of women treated with 131I for thyroid cancer
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
Safety Outcomes Post Kidney Biopsy – randomized clinical Evaluation of Efficacy of Desmopressin
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 2 clinical trial assessing the efficacy and safety of adding cladribine for treatment modifying course of seropositive myasthenia gravis
Sponsor Uniwersytet Medyczny W Lublinie
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicentre, randomised, double-blind, placebo-controlled phase III study, evaluating the effect of dapagliflozin on prevention of cardiotoxicity in breast cancer patients undergoing anthracycline-based chemotherapy (PROTECTAA).
Sponsor 4 Wojskowy Szpital Kliniczny Z Polikliniką Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclawiu
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndrome – a double-blind, randomized study.
Sponsor Medical University Of Warsaw
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.
Sponsor Nicolaus Copernicus University
- Start (EU)
- Latest update
- Estimated end
- Not reported
Optimal medical treatment of uncontrolled hypertension. OPTIMAL-HT
Sponsor Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparing high and lOw-dose asPirin with dual anTIplatelet therapy for three Months using prasUgrel and aSpirin following Coronary Artery Bypass Grafting. (OPTIMUS-CABG trial).
Sponsor Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Sacubitril/Valsartan in PriMAry preventIoN of the cardiotoxicity of systematic breaST canceR trEAtMent. Randomized, multicenter, double-blind, placebo-controlled study.
Sponsor Slaskie Centrum Chorob Serca W Zabrzu
- Start (EU)
- Latest update
- Estimated end
- Not reported
Sacubitril/valsartan in the prevention of disease progression in patients with an ancient arrhythmogenic service - ARNI-ARVC multicentre randomized trial
Sponsor Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Scientia Research Institute Sp. z o.o?
The 2026-10-09 snapshot links Scientia Research Institute Sp. z o.o to 11 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Safety reporting & pharmacovigilance, Electronic data capture, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Scientia Research Institute Sp. z o.o?
The most frequently recorded therapeutic areas are Cardiology, Endocrinology, Gynecology, Reproductive Medicine. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Scientia Research Institute Sp. z o.o conducted?
The linked trials record locations in 1 country, including Poland. These are trial locations, not confirmed office locations or countries where Scientia Research Institute Sp. z o.o delivered services.
What can this page tell me about Scientia Research Institute Sp. z o.o's trial experience?
Browse 11 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Scientia Research Institute Sp. z o.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Scientia Research Institute Sp. z o.o.